A panel of experts advising the Centers for Disease Control and Prevention is discussing rare blood clots that health officials have investigated in Johnson & Johnson coronavirus vaccine recipients.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
